Stock Exchange:
NEW YORK
Sector:
Biotechnology
Sub-sector:
Development
Turnover last year:
4.129 M$ 2023
Profits last year:
475 M$ 2023
Activity: Biotechnology.
Charles River Laboratories International, is a full-service non-clinical contract research organization (CRO).
https://www.criver.com/